April 11, 2017
The authorized generic (AG) market in Japan is expected to reach 81.7 billion yen (drug maker shipment basis) in 2020, growing by 3.4-fold from 2015, according to market research firm Fuji Keizai. As of January 2017, a total of 15...read more